Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin Model
Bioengineered artificial skin substitutes (BASS) are the main treatment used in addition to autografts when skin injuries involve a large body surface area. Antiseptic/antibiotic treatment is necessary to prevent infections in the BASS implant area. This study aims to evaluate the effect of antisept...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/4/642 |
id |
doaj-e4c723a6b1fc40a8ab392c1920c25e7c |
---|---|
record_format |
Article |
spelling |
doaj-e4c723a6b1fc40a8ab392c1920c25e7c2021-02-09T00:01:03ZengMDPI AGJournal of Clinical Medicine2077-03832021-02-011064264210.3390/jcm10040642Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin ModelMaría I. Quiñones-Vico0Ana Fernández-González1Elena Pérez-Castejón2Trinidad Montero-Vílchez3Salvador Arias-Santiago4Cell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, 18014 Granada, SpainCell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, 18014 Granada, SpainCell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, 18014 Granada, SpainBiosanitary Institute of Granada (ibs. GRANADA), 18014 Granada, SpainCell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, 18014 Granada, SpainBioengineered artificial skin substitutes (BASS) are the main treatment used in addition to autografts when skin injuries involve a large body surface area. Antiseptic/antibiotic treatment is necessary to prevent infections in the BASS implant area. This study aims to evaluate the effect of antiseptics and antibiotics on cell viability, structural integrity, and epidermal barrier function in BASS based on hyaluronic acid during a 28 day follow-up period. Keratinocytes (KTs) and dermal fibroblasts (DFs) were isolated from skin samples and used to establish BASS. The following antibiotic/antiseptic treatment was applied every 48 h: colistin (1%), chlorhexidine digluconate (1%), sodium chloride (0.02%), and polyhexanide (0.1%). Cell viability (LIVE/DEAD<sup>®</sup> assay), structural integrity (histological evaluation), and epidermal barrier function (trans-epidermal water loss, (TEWL), Tewameter<sup>®</sup>) were also evaluated. Cell viability percentage of BASS treated with chlorhexidine digluconate was significantly lower (<i>p</i> ≤ 0.001) than the other antiseptics at day 28. Compared to other treatments, chlorhexidine digluconate and polyhexanide significantly affected the epithelium. No significant differences were found regarding epidermal barrier. These results may be useful for treatment protocols after implantation of BASS in patients and evaluating them in clinical practice. BASS represent a suitable model to test in vitro the impact of different treatments of other skin wounds.https://www.mdpi.com/2077-0383/10/4/642antiseptic/antibiotic testingbioengineered artificial skin substitutecell viabilityepidermal barrier functionregenerative medicinewound healing |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
María I. Quiñones-Vico Ana Fernández-González Elena Pérez-Castejón Trinidad Montero-Vílchez Salvador Arias-Santiago |
spellingShingle |
María I. Quiñones-Vico Ana Fernández-González Elena Pérez-Castejón Trinidad Montero-Vílchez Salvador Arias-Santiago Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin Model Journal of Clinical Medicine antiseptic/antibiotic testing bioengineered artificial skin substitute cell viability epidermal barrier function regenerative medicine wound healing |
author_facet |
María I. Quiñones-Vico Ana Fernández-González Elena Pérez-Castejón Trinidad Montero-Vílchez Salvador Arias-Santiago |
author_sort |
María I. Quiñones-Vico |
title |
Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin Model |
title_short |
Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin Model |
title_full |
Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin Model |
title_fullStr |
Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin Model |
title_full_unstemmed |
Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin Model |
title_sort |
cytotoxicity and epidermal barrier function evaluation of common antiseptics for clinical use in an artificial autologous skin model |
publisher |
MDPI AG |
series |
Journal of Clinical Medicine |
issn |
2077-0383 |
publishDate |
2021-02-01 |
description |
Bioengineered artificial skin substitutes (BASS) are the main treatment used in addition to autografts when skin injuries involve a large body surface area. Antiseptic/antibiotic treatment is necessary to prevent infections in the BASS implant area. This study aims to evaluate the effect of antiseptics and antibiotics on cell viability, structural integrity, and epidermal barrier function in BASS based on hyaluronic acid during a 28 day follow-up period. Keratinocytes (KTs) and dermal fibroblasts (DFs) were isolated from skin samples and used to establish BASS. The following antibiotic/antiseptic treatment was applied every 48 h: colistin (1%), chlorhexidine digluconate (1%), sodium chloride (0.02%), and polyhexanide (0.1%). Cell viability (LIVE/DEAD<sup>®</sup> assay), structural integrity (histological evaluation), and epidermal barrier function (trans-epidermal water loss, (TEWL), Tewameter<sup>®</sup>) were also evaluated. Cell viability percentage of BASS treated with chlorhexidine digluconate was significantly lower (<i>p</i> ≤ 0.001) than the other antiseptics at day 28. Compared to other treatments, chlorhexidine digluconate and polyhexanide significantly affected the epithelium. No significant differences were found regarding epidermal barrier. These results may be useful for treatment protocols after implantation of BASS in patients and evaluating them in clinical practice. BASS represent a suitable model to test in vitro the impact of different treatments of other skin wounds. |
topic |
antiseptic/antibiotic testing bioengineered artificial skin substitute cell viability epidermal barrier function regenerative medicine wound healing |
url |
https://www.mdpi.com/2077-0383/10/4/642 |
work_keys_str_mv |
AT mariaiquinonesvico cytotoxicityandepidermalbarrierfunctionevaluationofcommonantisepticsforclinicaluseinanartificialautologousskinmodel AT anafernandezgonzalez cytotoxicityandepidermalbarrierfunctionevaluationofcommonantisepticsforclinicaluseinanartificialautologousskinmodel AT elenaperezcastejon cytotoxicityandepidermalbarrierfunctionevaluationofcommonantisepticsforclinicaluseinanartificialautologousskinmodel AT trinidadmonterovilchez cytotoxicityandepidermalbarrierfunctionevaluationofcommonantisepticsforclinicaluseinanartificialautologousskinmodel AT salvadorariassantiago cytotoxicityandepidermalbarrierfunctionevaluationofcommonantisepticsforclinicaluseinanartificialautologousskinmodel |
_version_ |
1724278926780399616 |